We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

197 hedge funds and large institutions have $477M invested in SANGAMO THERAPEUTICS INC in 2022 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 68 increasing their positions, 46 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 46

39% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 23

29% more capital invested

Capital invested by funds: $370M → $477M (+$107M)

24% more call options, than puts

Call options by funds: $2.45M | Put options by funds: $1.97M

5% more funds holding

Funds holding: 188 → 197 (+9)

1.07% more ownership

Funds ownership: 61.14% → 62.21% (+1.1%)

Holders
197
Holders Change
+9
Holders Change %
+4.79%
% of All Funds
3.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
68
Reduced
46
Closed
23
Calls
$2.45M
Puts
$1.97M
Net Calls
+$478K
Net Calls Change
-$539K

Top Buyers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
+$12.1M
2
N
Nuveen
North Carolina
+$11.6M
3
BlackRock
BlackRock
New York
+$9.75M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$6.19M
5
WA
Wasatch Advisors
Utah
+$3.75M

Top Sellers

Rank Fund Capital Flow
1
CC
Casdin Capital
New York
-$4.14M
2
State Street
State Street
Massachusetts
-$3.96M
3
Millennium Management
Millennium Management
New York
-$2.98M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$2.03M
5
Morgan Stanley
Morgan Stanley
New York
-$1.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
CM
201
Caption Management
Oklahoma
– -$183K -44,100 Closed
SAM
202
Shell Asset Management
Netherlands
– -$174K -42,138 Closed
DU
203
Delphia (USA)
Ontario, Canada
– -$130K -31,498 Closed
BCM
204
Bayesian Capital Management
New York
– -$128K -31,000 Closed
CC
205
Corton Capital
Ontario, Canada
– -$119K -28,707 Closed
Handelsbanken Fonder
206
Handelsbanken Fonder
Sweden
– -$117K -28,246 Closed
PHK
207
Point72 Hong Kong
Hong Kong
– -$116K -28,019 Closed
Balyasny Asset Management
208
Balyasny Asset Management
Illinois
– -$107K -25,900 Closed
PAG
209
Private Advisor Group
New Jersey
– -$52K -12,631 Closed
KAS
210
Kestra Advisory Services
Texas
– -$48K -11,518 Closed
BCM
211
Bourgeon Capital Management
Connecticut
– -$11K -2,550 Closed
AP
212
Arlington Partners
Alabama
– -$8K -2,000 Closed
CAPTRUST Financial Advisors
213
CAPTRUST Financial Advisors
North Carolina
– -$5K -1,238 Closed
RIM
214
Rockbridge Investment Management
New York
– -$3.75K -905 Closed
LC
215
Lindbrook Capital
California
– +$390 +76 New
5 6 7 8
9

SGMO Hedge Fund Activity: Q3 2022 in Review

197 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2022, worth a combined $477M — up 29% from $370M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new SGMO positions and 23 closed out — a net gain of 9 holders — while 68 added to existing stakes and 46 trimmed.

The largest buyer was Avidity Partners Management, opening a new position worth an estimated $12.1M. The largest seller was Casdin Capital, exiting entirely with an estimated $4.14M sold.

  • 197 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2022, up from 188 in Q2 2022.
  • Funds reported $477M of SANGAMO THERAPEUTICS INC stock for Q3 2022, up 29% quarter-over-quarter.
  • 32 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2022 and 23 closed out, a net change of +9 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q3 2022 was Avidity Partners Management, an estimated $12.1M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q3 2022 was Casdin Capital, an estimated $4.14M sold.

Based on aggregated 13F filings for Q3 2022.